The contribution of molecular alterations in bone marrow mesenchymal stromal cells (BM-MSC) to the pathogenesis of acute myeloid leukemia (AML) is poorly understood. Thus we assessed genome-wide ...
Collectively, array studies have identified new clonal deletions and amplifications that probably contribute to disease pathogenesis ... and less progression to AML (p = 0.033) [11] Graubert ...
ALL = Acute lymphoblastic leukemia; AML = Acute myeloid leukemia; FTI = Farnesyltransferase inhibitor; HDAC = Histone deacetylase; NF = Nuclear factor; Ph = Philadelphia chromosome; TKI = Tyrosine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback